Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 61
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Bioorg Chem ; 144: 107113, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38232685

ABSTRACT

Liver fibrosis is an abnormal wound-healing response to liver injuries. It can lead to liver cirrhosis, and even liver cancer and liver failure. There is a lack of treatment for liver fibrosis and it is of great importance to develop anti-fibrotic drugs. A pivotal event in the process of developing liver fibrosis is the activation of hepatic stellate cells (HSCs), in which the nuclear receptor Nur77 plays a crucial role. This study aimed to develop novel anti-fibrotic agents with Nur77 as the drug target by modifying the structure of THPN, a Nur77-binding and anti-melanoma compound. Specifically, a series of para-positioned 3,4,5-trisubstituted benzene ring compounds with long-chain backbone were generated and tested for anti-fibrotic activity. Among these compounds, compound A8 was with the most potent and Nur77-dependent inhibitory activity against TGF-ß1-induced activation of HSCs. In a crystal structure analysis, compound A8 bound Nur77 in a peg-in-hole mode as THPN did but adopted a different conformation that could interfere the Nur77 interaction with AKT, which was previous shown to be important for an anti-fibrotic activity. In a cell-based assay, compound A8 indeed impeded the interaction between Nur77 and AKT leading to the stabilization of Nur77 without the activation of AKT. In a mouse model, compound A8 effectively suppressed the activation of AKT signaling pathway and up-regulated the cellular level of Nur77 to attenuate the HSCs activation and ameliorate liver fibrosis with no significant toxic side effects. Collectively, this work demonstrated that Nur77-targeting compound A8 is a promising anti-fibrotic drug candidate.


Subject(s)
Benzene , Proto-Oncogene Proteins c-akt , Mice , Animals , Fibrosis , Liver Cirrhosis/chemically induced , Liver Cirrhosis/drug therapy , Liver Cirrhosis/metabolism
2.
Proc Natl Acad Sci U S A ; 117(44): 27412-27422, 2020 11 03.
Article in English | MEDLINE | ID: mdl-33087562

ABSTRACT

Nuclear receptor Nur77 participates in multiple metabolic regulations and plays paradoxical roles in tumorigeneses. Herein, we demonstrated that the knockout of Nur77 stimulated mammary tumor development in two mouse models, which would be reversed by a specific reexpression of Nur77 in mammary tissues. Mechanistically, Nur77 interacted and recruited corepressors, the SWI/SNF complex, to the promoters of CD36 and FABP4 to suppress their transcriptions, which hampered the fatty acid uptake, leading to the inhibition of cell proliferation. Peroxisome proliferator-activated receptor-γ (PPARγ) played an antagonistic role in this process through binding to Nur77 to facilitate ubiquitin ligase Trim13-mediated ubiquitination and degradation of Nur77. Cocrystallographic and functional analysis revealed that Csn-B, a Nur77-targeting compound, promoted the formation of Nur77 homodimer to prevent PPARγ binding by steric hindrance, thereby strengthening the Nur77's inhibitory role in breast cancer. Therefore, our study reveals a regulatory function of Nur77 in breast cancer via impeding fatty acid uptake.


Subject(s)
Breast Neoplasms/pathology , Nuclear Receptor Subfamily 4, Group A, Member 1/metabolism , PPAR gamma/metabolism , Phenylacetates/pharmacology , Adult , Aged , Aged, 80 and over , Animals , Breast/pathology , Breast Neoplasms/drug therapy , Breast Neoplasms/mortality , Cell Proliferation , DNA-Binding Proteins/metabolism , Disease Models, Animal , Disease Progression , Fatty Acids/metabolism , Female , Humans , Kaplan-Meier Estimate , Lipid Metabolism/drug effects , Mammary Glands, Animal/pathology , Mice , Middle Aged , Nuclear Receptor Subfamily 4, Group A, Member 1/agonists , PPAR gamma/agonists , Primary Cell Culture , Prognosis , Proteolysis/drug effects , Tissue Array Analysis , Tumor Cells, Cultured , Tumor Suppressor Proteins/metabolism , Ubiquitination/drug effects
3.
Fish Shellfish Immunol ; 128: 474-483, 2022 Sep.
Article in English | MEDLINE | ID: mdl-35988710

ABSTRACT

The freshwater amphibious snail Oncomelania hupensis is the unique intermediate host of Schistosoma japonicum, but little attention has been paid to the interaction between the two. In snails, the production of reactive oxygen species (ROS) by hemocytes has been shown to be vital for snail immune defense against schistosome infection. However, excessive ROS accumulation could lead to oxidative damage, requiring the antioxidant system for maintaining the cellular redox homeostasis. Previously we identified a thioredoxin-related protein of 14 kDa from O. hupensis (OhTRP14), and showed that it was involved in the scavenging of ROS in circulating hemocytes. Here, we confirmed that OhTRP14 plays a potential role in the snail host response to parasite challenge and determined the crystal structures of OhTRP14 in two different states (oxidized and transition state). The overall structure revealed a typical Trx fold and is similar to that of human TRP14 (hTRP14), but there were significant structural differences between the two states. Noticeably, there was a different pair of thiol groups from Cys30 and Cys44 in the transition state of OhTRP14, were with the similar separation of 2.9 Å as that (2.6 Å) between Cys41 and Cys44, but in a different orientation, suggesting that the Cys30 is likely to function as an important molecular switch involved in the oxidoreductase activity of OhTRP14. Comparative studies between OhTRP14 and hTRP14 by analyzing the surface characteristics, charge distribution and oxidoreductase activity toward insulin demonstrated they might have similar substrates. The results are expected to provide structural insights into the redox regulation of OhTRP14 and contribute to better understanding of TRP14 family. DATA DEPOSITION: The atomic coordinates of the structure and the structure factors were deposited in Protein Data Bank with PDB ID codes 7XQ3 and 7XPW.


Subject(s)
Insulins , Parasites , Animals , Antioxidants , China , Humans , Oxidation-Reduction , Oxidoreductases , Reactive Oxygen Species , Snails , Sulfhydryl Compounds , Thioredoxins/genetics
4.
Biochem J ; 477(12): 2133-2151, 2020 06 26.
Article in English | MEDLINE | ID: mdl-32484230

ABSTRACT

Oncomelania hupensis is the unique intermediate host of Schistosoma japonicum. As an irreplaceable prerequisite in the transmission and prevalence of schistosomiasis japonica, an in-depth study of this obligate host-parasite interaction can provide glimpse into the molecular events in the competition between schistosome infectivity and snail immune resistance. In previous studies, we identified a macrophage migration inhibitory factor (MIF) from O. hupensis (OhMIF), and showed that it was involved in the snail host immune response to the parasite S. japonicum. Here, we determined the crystal structure of OhMIF and revealed that there were distinct structural differences between the mammalian and O. hupensis MIFs. Noticeably, there was a projecting and structured C-terminus in OhMIF, which not only regulated the MIF's thermostability but was also critical in the activation of its tautomerase activity. Comparative studies between OhMIF and human MIF (hMIF) by analyzing the tautomerase activity, oxidoreductase activity, thermostability, interaction with the receptor CD74 and activation of the ERK signaling pathway demonstrated the functional differences between hMIF and OhMIF. Our data shed a species-specific light on structural, functional, and immunological characteristics of OhMIF and enrich the knowledge on the MIF family.


Subject(s)
Isomerases/metabolism , MAP Kinase Signaling System , Macrophage Migration-Inhibitory Factors/chemistry , Macrophage Migration-Inhibitory Factors/metabolism , Snails/physiology , Amino Acid Sequence , Animals , Catalytic Domain , Protein Conformation , Sequence Homology , Substrate Specificity
5.
Bioorg Med Chem ; 28(12): 115551, 2020 06 15.
Article in English | MEDLINE | ID: mdl-32503695

ABSTRACT

We describe here the design, synthesis, and evaluation of a macrocyclic peptidomimetic as a potent agent targeting enterovirus A71 (EV71). The compound has a 15-membered macrocyclic ring in a defined conformation. Yamaguchi esterification reaction was used to close the 15-membered macrocycle instead of the typical Ru-catalyzed ring-closing olefin metathesis reaction. The crystallographic characterization of the complex between this compound and its target, 3C protease from EV71, validated the design and paved the way for the generation of a new series of anti-EV71 agents.


Subject(s)
Antiviral Agents/chemical synthesis , Drug Design , Macrocyclic Compounds/chemistry , 3C Viral Proteases/chemistry , 3C Viral Proteases/metabolism , Animals , Antiviral Agents/blood , Antiviral Agents/metabolism , Antiviral Agents/pharmacology , Binding Sites , Catalysis , Catalytic Domain , Cell Line, Tumor , Cell Survival/drug effects , Crystallography, X-Ray , Drug Stability , Enterovirus A, Human/drug effects , Enterovirus A, Human/enzymology , Esterification , Humans , Macrocyclic Compounds/blood , Macrocyclic Compounds/metabolism , Macrocyclic Compounds/pharmacology , Mice , Molecular Dynamics Simulation , Ruthenium/chemistry
6.
Biochim Biophys Acta ; 1860(6): 1299-307, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26987809

ABSTRACT

BACKGROUND: Enterovirus 71 (EV71) is a causative agent of hand, foot and mouth disease (HFMD), which can spread its infection to central nervous and other systems with severe consequence. A key factor in the replication of EV71 is its 3C proteinase (3C(pro)), a significant drug target. Peptidomimetics were employed as inhibitors of this enzyme for developing antivirals. However, the peptide bonds in these peptidomimetics are a source of low bioavailability due to their susceptibility to protease digestion. To produce non-peptidomimetic inhibitors by replacing these peptide bonds, it would be important to gain better understanding on the contribution of each component to the interaction and potency. METHODS: A series of compounds of different lengths targeting 3C(pro) and having an α,ß-unsaturated ester as the warhead were synthesized and their interactions with the enzyme were evaluated by complex structure analyses and potency assays for a better understanding on the relationship between potency and evolution of interaction. RESULTS: The P2 moiety of the compound would need to be oriented to interact in the S2 site in the substrate binding cleft and the P3-P4 moieties were required to generate sufficient potency. A hydrophobic terminal group will benefit the cellular uptake and improve the activity in vivo. CONCLUSIONS AND GENERAL SIGNIFICANCE: The data presented here provide a basis for designing a new generation of non-peptidomimetics to target EV71 3C(pro).


Subject(s)
Cysteine Proteinase Inhibitors/pharmacology , Enterovirus A, Human/drug effects , Viral Proteins/antagonists & inhibitors , 3C Viral Proteases , Amino Acid Sequence , Cysteine Endopeptidases/chemistry , Drug Design , Enterovirus A, Human/enzymology , Molecular Sequence Data , Structure-Activity Relationship , Viral Proteins/chemistry
7.
Nat Chem Biol ; 11(5): 339-46, 2015 May.
Article in English | MEDLINE | ID: mdl-25822914

ABSTRACT

Sepsis, a hyperinflammatory response that can result in multiple organ dysfunctions, is a leading cause of mortality from infection. Here, we show that orphan nuclear receptor Nur77 (also known as TR3) can enhance resistance to lipopolysaccharide (LPS)-induced sepsis in mice by inhibiting NF-κB activity and suppressing aberrant cytokine production. Nur77 directly associates with p65 to block its binding to the κB element. However, this function of Nur77 is countered by the LPS-activated p38α phosphorylation of Nur77. Dampening the interaction between Nur77 and p38α would favor Nur77 suppression of the hyperinflammatory response. A compound, n-pentyl 2-[3,5-dihydroxy-2-(1-nonanoyl) phenyl]acetate, screened from a Nur77-biased library, blocked the Nur77-p38α interaction by targeting the ligand-binding domain of Nur77 and restored the suppression of the hyperinflammatory response through Nur77 inhibition of NF-κB. This study associates the nuclear receptor with immune homeostasis and implicates a new therapeutic strategy to treat hyperinflammatory responses by targeting a p38α substrate to modulate p38α-regulated functions.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Inflammation/prevention & control , Lipopolysaccharides/toxicity , Nuclear Receptor Subfamily 4, Group A, Member 1/drug effects , Phenylacetates/pharmacology , p38 Mitogen-Activated Protein Kinases/drug effects , Animals , Diabetes Mellitus, Type 2/complications , Drug Evaluation, Preclinical , Homeostasis/drug effects , Inflammation/chemically induced , Ligands , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Models, Molecular , Molecular Conformation , Sepsis/drug therapy , Sepsis/genetics , Transcription Factor RelA/antagonists & inhibitors
8.
Neurochem Res ; 42(12): 3456-3464, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29019029

ABSTRACT

This study is to determine the role and mechanism of hippocampal acetylation in prenatal stress (PS) induced depression-like behavior of male offspring rats. PS-induced depression rat model was established. Sucrose preference and forced swim test were used to observe the behavior changes of male offspring rats. Hippocampal acetylation was induced by Trichostatin A injection. Quantitative real-time PCR and Western blot were used to determine the changes of AMPARs in acetylated hippocampus. The behavioral tests proved that AMPA was involved in the PS-induced depression-like behavior in offspring rats. Hippocampal acetylation significantly increased the preference to sucrose of PS-induced offspring rats and reduced the immobile time in forced swimming test, suggesting that acetylation could improve PS-induced depression-like behaviors. In addition, PS inhibited the expression levels of GluA1-3 subunits of AMPARs in the offspring hippocampus, while Hippocampal acetylation could reverse this effect by increasing GluA1-3 expression. PS-induced reduction of GluA1-3 subunits of AMPARs may be an important potential mechanism of offspring depression. Hippocampal acetylation may improve PS-induced offspring depression-like behavior through the enhanced expression of AMPARs (GluA1-3 subunits).


Subject(s)
Acetylation/drug effects , Depression/metabolism , Hippocampus/metabolism , Prenatal Exposure Delayed Effects/metabolism , Stress, Psychological/metabolism , Animals , Behavior, Animal/physiology , Depressive Disorder/metabolism , Disease Models, Animal , Female , Pregnancy , Rats, Sprague-Dawley
9.
Mol Microbiol ; 95(5): 791-803, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25430994

ABSTRACT

Pyrazinamide (PZA) is a first-line drug for tuberculosis (TB) treatment and is responsible for shortening the duration of TB therapy. The mode of action of PZA remains elusive. RpsA, the ribosomal protein S1 of Mycobacterium tuberculosis (Mtb), was recently identified as a target of PZA based on its binding activity to pyrazinoic acid (POA), the active form of PZA. POA binding to RpsA led to the inhibition of trans-translation. However, the nature of the RpsA-POA interaction remains unknown. Key questions include why POA exhibits an exquisite specificity to RpsA of Mtb and how RpsA mutations confer PZA resistance. Here, we report the crystal structures of the C-terminal domain of RpsA of Mtb and its complex with POA, as well as the corresponding domains of two RpsA variants that are associated with PZA resistance. Structural analysis reveals that POA binds to RpsA through hydrogen bonds and hydrophobic interactions, mediated mainly by residues (Lys303, Phe307, Phe310 and Arg357) that are essential for tmRNA binding. Conformational changes induced by mutation or sequence variation at the C-terminus of RpsA abolish the POA binding activity. Our findings provide insights into the mode of action of PZA and molecular basis of PZA resistance associated with RpsA mutations.


Subject(s)
Antitubercular Agents/pharmacology , Mycobacterium tuberculosis/drug effects , Pyrazinamide/pharmacology , Ribosomal Proteins/chemistry , Ribosomal Proteins/metabolism , Antitubercular Agents/metabolism , Crystallography, X-Ray , Microbial Sensitivity Tests , Molecular Structure , Mutation , Mycobacterium tuberculosis/genetics , Protein Structure, Tertiary , Pyrazinamide/analogs & derivatives , Pyrazinamide/metabolism , RNA, Bacterial/metabolism , Ribosomal Proteins/genetics , Sequence Alignment , Thermodynamics
10.
J Mol Recognit ; 29(11): 520-527, 2016 11.
Article in English | MEDLINE | ID: mdl-27185390

ABSTRACT

Enterovirus 71 (EV71) is the causative agent of hand, foot and mouth disease and can spread its infections to the central nervous and other systems with severe consequences. The replication of EV71 depends on its 3C proteinase (3Cpro ), a significant drug target. By X-ray crystallography and functional assays, the interactions between inhibitors and EV71 3Cpro were evaluated. It was shown that improved interactions at S4 for the substrate binding could significantly enhance the potency. A new series of potent inhibitors with high ligand efficiency was generated for developing antivirals to treat and control the EV71-associated diseases. Copyright © 2016 John Wiley & Sons, Ltd.


Subject(s)
Antiviral Agents/chemical synthesis , Cysteine Proteinase Inhibitors/chemical synthesis , Enterovirus A, Human/enzymology , Viral Proteins/antagonists & inhibitors , 3C Viral Proteases , Antiviral Agents/chemistry , Antiviral Agents/pharmacology , Cell Line , Crystallography, X-Ray , Cysteine Endopeptidases/chemistry , Cysteine Proteinase Inhibitors/chemistry , Cysteine Proteinase Inhibitors/pharmacology , Enterovirus A, Human/drug effects , Humans , Models, Molecular , Structure-Activity Relationship , Substrate Specificity , Viral Proteins/chemistry
11.
Nat Chem Biol ; 10(2): 133-40, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24316735

ABSTRACT

Autophagy is linked to cell death, yet the associated mechanisms are largely undercharacterized. We discovered that melanoma, which is generally resistant to drug-induced apoptosis, can undergo autophagic cell death with the participation of orphan nuclear receptor TR3. A sequence of molecular events leading to cellular demise is launched by a specific chemical compound, 1-(3,4,5-trihydroxyphenyl)nonan-1-one, newly acquired from screening a library of TR3-targeting compounds. The autophagic cascade comprises TR3 translocation to mitochondria through interaction with the mitochondrial outer membrane protein Nix, crossing into the mitochondrial inner membrane through Tom40 and Tom70 channel proteins, dissipation of mitochondrial membrane potential by the permeability transition pore complex ANT1-VDAC1 and induction of autophagy. This process leads to excessive mitochondria clearance and irreversible cell death. It implicates a new approach to melanoma therapy through activation of a mitochondrial signaling pathway that integrates a nuclear receptor with autophagy for cell death.


Subject(s)
Autophagy , Ketones/chemistry , Mitochondria/physiology , Nuclear Receptor Subfamily 4, Group A, Member 1/metabolism , Pyrogallol/analogs & derivatives , Signal Transduction , Animals , Cell Line, Tumor , Crystallography, X-Ray , Disease Models, Animal , Humans , Ketones/pharmacology , Melanoma/drug therapy , Membrane Proteins/metabolism , Mice , Protein Conformation , Proto-Oncogene Proteins/metabolism , Pyrogallol/chemistry , Pyrogallol/pharmacology , Tumor Suppressor Proteins/metabolism
12.
Bioorg Med Chem Lett ; 26(14): 3346-3350, 2016 07 15.
Article in English | MEDLINE | ID: mdl-27234148

ABSTRACT

Enterovirus 71 (EV71) is a major causative agent of hand, foot and mouth disease (HFMD), which can spread its infections to the central nervous and other systems with severe consequences. In this article, design, chemical synthesis, and biological evaluation of various anti-EV71 agents which incorporate Michael acceptors are described. Further SAR study demonstrated that lactone type of Michael acceptor provided a new lead of anti-EV71 drug candidates with high anti-EV71 activity in cell-based assay and enhanced mouse plasma stability. One of the most potent compounds (2K, cell-based anti-EV71 EC50=0.028µM), showed acceptable stability profile towards mouse plasma, which resulted into promising pharmacokinetics in mouse via IP administration.


Subject(s)
Antiviral Agents/pharmacology , Drug Design , Enterovirus A, Human/drug effects , Animals , Antiviral Agents/blood , Antiviral Agents/chemical synthesis , Cell Death/drug effects , Cell Line, Tumor , Dose-Response Relationship, Drug , Humans , Mice , Microbial Sensitivity Tests , Models, Molecular , Molecular Structure , Structure-Activity Relationship
13.
J Virol ; 87(13): 7348-56, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23616646

ABSTRACT

The 2A proteinase (2A(pro)) is an enterovirally encoded cysteine protease that plays essential roles in both the processing of viral precursor polyprotein and the hijacking of host cell translation and other processes in the virus life cycle. Crystallographic studies of 2A(pro) from enterovirus 71 (EV71) and its interaction with the substrate are reported here. EV71 2A(pro) was comprised of an N-terminal domain of a four-stranded antiparallel ß sheet and a C-terminal domain of a six-stranded antiparallel ß barrel with a tightly bound zinc atom. Unlike in other 2A(pro) structures, there is an open cleft across the surface of the protein in an open conformation. As demonstrated by the crystallographic studies and modeling of the complex structure, the open cleft could be fitted with the substrate. On comparison 2A(pro) of EV71 to those of the human rhinovirus 2 and coxsackievirus B4, the open conformation could be closed with a hinge motion in the bII2 and cII ß strands. This was supported by molecular dynamic simulation. The structural variation among different 2A(pro) structures indicates a conformational flexibility in the substrate-binding cleft. The open structure provides an accessible framework for the design and development of therapeutics against the viral target.


Subject(s)
Cysteine Endopeptidases/chemistry , Enterovirus A, Human/enzymology , Models, Molecular , Protein Conformation , Amino Acid Sequence , Crystallography, X-Ray , Cysteine Endopeptidases/genetics , Escherichia coli , Fluorescence Resonance Energy Transfer , Genetic Vectors/genetics , Molecular Sequence Data , Mutagenesis , Polymerase Chain Reaction , Sequence Alignment
14.
Nat Chem Biol ; 8(11): 897-904, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22983157

ABSTRACT

Liver kinase B1 (LKB1) has important roles in governing energy homeostasis by regulating the activity of the energy sensor kinase AMP-activated protein kinase (AMPK). The regulation of LKB1 function, however, is still poorly understood. Here we demonstrate that the orphan nuclear receptor Nur77 binds and sequesters LKB1 in the nucleus, thereby attenuating AMPK activation. This Nur77 function is antagonized by the chemical compound ethyl 2-[2,3,4-trimethoxy-6-(1-octanoyl)phenyl]acetate (TMPA), which interacts with Nur77 with high affinity and at specific sites. TMPA binding of Nur77 results in the release and shuttling of LKB1 to the cytoplasm to phosphorylate AMPKα. Moreover, TMPA effectively reduces blood glucose and alleviates insulin resistance in type II db/db and high-fat diet- and streptozotocin-induced diabetic mice but not in diabetic littermates with the Nur77 gene knocked out. This study attains a mechanistic understanding of the regulation of LKB1-AMPK axis and implicates Nur77 as a new and amenable target for the design and development of therapeutics to treat metabolic diseases.


Subject(s)
AMP-Activated Protein Kinases/metabolism , Nuclear Receptor Subfamily 4, Group A, Member 1/metabolism , Phenylacetates/pharmacology , Protein Serine-Threonine Kinases/metabolism , AMP-Activated Protein Kinase Kinases , AMP-Activated Protein Kinases/antagonists & inhibitors , Animals , Blood Glucose/drug effects , Cells, Cultured , Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Experimental/drug therapy , Diabetes Mellitus, Experimental/metabolism , Enzyme Activation/drug effects , HEK293 Cells , Humans , Insulin Resistance , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Obese , Models, Molecular , Nuclear Receptor Subfamily 4, Group A, Member 1/antagonists & inhibitors , Nuclear Receptor Subfamily 4, Group A, Member 1/genetics , Phenylacetates/chemistry , Phosphorylation/drug effects , Protein Serine-Threonine Kinases/antagonists & inhibitors , Protein Transport/drug effects , Streptozocin , Structure-Activity Relationship
15.
Acta Crystallogr D Biol Crystallogr ; 69(Pt 5): 866-71, 2013 May.
Article in English | MEDLINE | ID: mdl-23633597

ABSTRACT

The crystal structure of 3C proteinase (3C(pro)) from Enterovirus 71 (EV71) was determined in space group C2221 to 2.2 Šresolution. The fold was similar to that of 3C(pro) from other picornaviruses, but the difference in the ß-ribbon reported in a previous structure was not observed. This ß-ribbon was folded over the substrate-binding cleft and constituted part of the essential binding sites for interaction with the substrate. The structure of its complex with rupintrivir (AG7088), a peptidomimetic inhibitor, was also characterized in space group P212121 to 1.96 Šresolution. The inhibitor was accommodated without any spatial hindrance despite the more constricted binding site; this was confirmed by functional assays, in which the inhibitor showed comparable potency towards EV71 3C(pro) and human rhinovirus 3C(pro), which is the target that rupintrivir was designed against.


Subject(s)
Antiviral Agents/chemistry , Cysteine Endopeptidases/chemistry , Cysteine Endopeptidases/metabolism , Enterovirus A, Human/enzymology , Isoxazoles/chemistry , Pyrrolidinones/chemistry , Viral Proteins/chemistry , Viral Proteins/metabolism , 3C Viral Proteases , Amino Acid Sequence , Antiviral Agents/pharmacology , Binding Sites , Catalytic Domain , Cell Line/drug effects , Cell Line/virology , Conserved Sequence , Crystallography, X-Ray , Cysteine Proteinase Inhibitors/chemistry , Cysteine Proteinase Inhibitors/pharmacology , Humans , Isoxazoles/metabolism , Isoxazoles/pharmacology , Models, Molecular , Molecular Sequence Data , Phenylalanine/analogs & derivatives , Protein Conformation , Pyrrolidinones/metabolism , Pyrrolidinones/pharmacology , Valine/analogs & derivatives , Viral Proteins/antagonists & inhibitors
16.
IEEE Trans Neural Netw Learn Syst ; 34(10): 7404-7417, 2023 Oct.
Article in English | MEDLINE | ID: mdl-35108207

ABSTRACT

Image style transfer aims at synthesizing an image with the content from one image and the style from another. User studies have revealed that the semantic correspondence between style and content greatly affects subjective perception of style transfer results. While current studies have made great progress in improving the visual quality of stylized images, most methods directly transfer global style statistics without considering semantic alignment. Current semantic style transfer approaches still work in an iterative optimization fashion, which is impractically computationally expensive. Addressing these issues, we introduce a novel dual-affinity style embedding network (DaseNet) to synthesize images with style aligned at semantic region granularity. In the dual-affinity module, feature correlation and semantic correspondence between content and style images are modeled jointly for embedding local style patterns according to semantic distribution. Furthermore, the semantic-weighted style loss and the region-consistency loss are introduced to ensure semantic alignment and content preservation. With the end-to-end network architecture, DaseNet can well balance visual quality and inference efficiency for semantic style transfer. Experimental results on different scene categories have demonstrated the effectiveness of the proposed method.

17.
Cell Chem Biol ; 30(3): 261-277.e8, 2023 03 16.
Article in English | MEDLINE | ID: mdl-36889311

ABSTRACT

Pulmonary fibrosis is a typical sequela of coronavirus disease 2019 (COVID-19), which is linked with a poor prognosis for COVID-19 patients. However, the underlying mechanism of pulmonary fibrosis induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unclear. Here, we demonstrated that the nucleocapsid (N) protein of SARS-CoV-2 induced pulmonary fibrosis by activating pulmonary fibroblasts. N protein interacted with the transforming growth factor ß receptor I (TßRI), to disrupt the interaction of TßRI-FK506 Binding Protein12 (FKBP12), which led to activation of TßRI to phosphorylate Smad3 and boost expression of pro-fibrotic genes and secretion of cytokines to promote pulmonary fibrosis. Furthermore, we identified a compound, RMY-205, that bound to Smad3 to disrupt TßRI-induced Smad3 activation. The therapeutic potential of RMY-205 was strengthened in mouse models of N protein-induced pulmonary fibrosis. This study highlights a signaling pathway of pulmonary fibrosis induced by N protein and demonstrates a novel therapeutic strategy for treating pulmonary fibrosis by a compound targeting Smad3.


Subject(s)
COVID-19 , Pulmonary Fibrosis , Animals , Mice , COVID-19/complications , Fibrosis , Nucleocapsid Proteins/therapeutic use , Pulmonary Fibrosis/complications , Pulmonary Fibrosis/drug therapy , SARS-CoV-2
18.
IEEE Trans Pattern Anal Mach Intell ; 44(12): 9814-9829, 2022 12.
Article in English | MEDLINE | ID: mdl-34855585

ABSTRACT

Weakly supervised temporal action localization aims at learning the instance-level action pattern from the video-level labels, where a significant challenge is action-context confusion. To overcome this challenge, one recent work builds an action-click supervision framework. It requires similar annotation costs but can steadily improve the localization performance when compared to the conventional weakly supervised methods. In this paper, by revealing that the performance bottleneck of the existing approaches mainly comes from the background errors, we find that a stronger action localizer can be trained with labels on the background video frames rather than those on the action frames. To this end, we convert the action-click supervision to the background-click supervision and develop a novel method, called BackTAL. Specifically, BackTAL implements two-fold modeling on the background video frames, i.e., the position modeling and the feature modeling. In position modeling, we not only conduct supervised learning on the annotated video frames but also design a score separation module to enlarge the score differences between the potential action frames and backgrounds. In feature modeling, we propose an affinity module to measure frame-specific similarities among neighboring frames and dynamically attend to informative neighbors when calculating temporal convolution. Extensive experiments on three benchmarks are conducted, which demonstrate the high performance of the established BackTAL and the rationality of the proposed background-click supervision.


Subject(s)
Algorithms , Benchmarking
19.
Ann Transl Med ; 10(16): 876, 2022 Aug.
Article in English | MEDLINE | ID: mdl-36111042

ABSTRACT

Background: Skeletal Class II malocclusion is a common malocclusion that seriously affects patients' profile and occlusal function. The key to treatment is to use functional appliances guide the mandible forward. This study aimed to evaluate the clinical efficacy of traditional functional appliance Twin Block (TB) and invisible functional appliance (A6). Methods: In the retrospective cohort study, 46 patients with Class II Division 1 mandibular retrognathia (23 females, 23 males; mean age 13.66±4.25 years) from the Third Affiliated Hospital of Sun Yat-sen University were selected. They were divided into A6 group and TB group according to the type of appliance guided mandibular forward used in orthodontic treatment (n=23 each; average treatment time 9.82±3.52 months). Lateral cephalometric radiographs were taken before and at the end of each treatment, and paired t-test or paired rank-sum tests were performed when appropriate to detect any statistical significance at the level of α=0.05. Results: The baseline characteristics of the two groups of patients were similar. Treatment with both appliances helped correct Class II malocclusion, improve the discrepancy between the maxilla and mandible, reduce the labial inclination of the maxillary anterior teeth, and relieve the deep overbite. A comparison of the treatment effects of the TB and A6 groups showed that the A6 had a better effect when moving Point A backward, and performed better in the abduction of the anterior teeth. TB group has more advantages than A6 group in moving forward point B and improving the nasolabial angle. Conclusions: Both the A6 and TB can significantly improve Class II malocclusion. A6 showed an obvious advantage in moving Point A backward and adducting the anterior teeth, which better corrects a skeletal Class II malocclusion.

20.
Nat Metab ; 4(10): 1306-1321, 2022 10.
Article in English | MEDLINE | ID: mdl-36192599

ABSTRACT

Extracellular vesicles play crucial roles in intercellular communication in the tumor microenvironment. Here we demonstrate that in hepatic fibrosis, TGF-ß stimulates the palmitoylation of hexokinase 1 (HK1) in hepatic stellate cells (HSCs), which facilitates the secretion of HK1 via large extracellular vesicles in a TSG101-dependent manner. The large extracellular vesicle HK1 is hijacked by hepatocellular carcinoma (HCC) cells, leading to accelerated glycolysis and HCC progression. In HSCs, the nuclear receptor Nur77 transcriptionally activates the expression of depalmitoylase ABHD17B to inhibit HK1 palmitoylation, consequently attenuating HK1 release. However, TGF-ß-activated Akt functionally represses Nur77 by inducing Nur77 phosphorylation and degradation. We identify the small molecule PDNPA that binds Nur77 to generate steric hindrance to block Akt targeting, thereby disrupting Akt-mediated Nur77 degradation and preserving Nur77 inhibition of HK1 release. Together, this study demonstrates an overlooked function of HK1 in HCC upon its release from HSCs and highlights PDNPA as a candidate compound for inhibiting HCC progression.


Subject(s)
Carcinoma, Hepatocellular , Extracellular Vesicles , Liver Neoplasms , Humans , Carcinoma, Hepatocellular/metabolism , Carcinoma, Hepatocellular/pathology , Hepatic Stellate Cells/metabolism , Hexokinase/metabolism , Liver Neoplasms/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Cell Proliferation , Cell Line, Tumor , Extracellular Vesicles/metabolism , Transforming Growth Factor beta/metabolism , Receptors, Cytoplasmic and Nuclear/metabolism , Tumor Microenvironment
SELECTION OF CITATIONS
SEARCH DETAIL